• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human ORC ubiquitin ligase 1 (OBI1), Truncated

ACP02071

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP02071 Target NameOBI1
Target SynonymsRING finger protein 219FormLiquid or Lyophilized powder
Expression SystemE.coliExpression Range78-613aa
Mol Weight67.5 kDaProtein LengthPartial
PurityGreater than 85% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ5W0B1
Background Information
  • Uniprot Id

    Q5W0B1

  • Target Species

    Human

  • Target Name

    OBI1

  • Target Full Name

    ORC ubiquitin ligase 1

  • Target Function

    E3 ubiquitin ligase essential for DNA replication origin activation during S phase. Acts as a replication origin selector which selects the origins to be fired and catalyzes the multi-mono-ubiquitination of a subset of chromatin-bound ORC3 and ORC5 during S-phase.

  • Target Subcellular Location

    Chromosome.

  • Target Research Area

    Others

  • Target Synonyms

    2610206B13Rik; 2810449K13Rik; AI451544; DKFZp686A01276; DKFZp686N15250; DKFZp686O03173; FLJ13449; FLJ25774; MGC35679; RGD1564706; RING finger protein 219; RING finger protein C13orf7; RN219_HUMAN; RNF219

  • Target Background

    Enables chromatin binding activity and ubiquitin-protein transferase activity. Involved in protein autoubiquitination; protein monoubiquitination; and regulation of DNA replication. Located in chromatin.

Inquire Recombinant Human ORC ubiquitin ligase 1 (OBI1), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification